Navigation Links
Drinking Coffee Might Have Another Benefit ...

Latest research shows that drinking coffee could decrease the risk of liver cancer.Researchers from Japan// pooled data from two cohort studies that showed self-reported frequency of coffee consumption among more than 60,000 people.

After adjustment for potential confounders, researchers say they found that those who drink coffee occasionally reduced their risk by almost 30 per cent, while those drinking one or more cups a day had a risk of just 0.58 compared with the non-drinkers. Although case-control studies suggest that coffee consumption is associated with a decreased risk of liver cancer, no prospective cohort study has been carried out to prove the same say researchers.

Japanese researchers also said that according to their study it was seen that people who drank coffee on a daily or almost daily basis had about half the risk of developing hepatocellular carcinoma, a type of liver cancer, compared with those who never drank coffee and subjects with a history of liver disease were found to have a significant inverse association between coffee consumption and the risk of liver cancer. Thus in conclusion researchers say further studies should be done to investigate the role of coffee in prevention of liver cancer.

Links from medindia : http://www.medindia.net/beat_heat
/6.asp

'"/>




Page: 1

Related medicine news :

1. Drinking arsenic water leads to cancer
2. Alcoholism Drug Fails To Prevent Drinking Relapses
3. Heavy Drinking Raises Risk of Liver Cancer
4. Drinking wine as part of a healthy living
5. Drinking adequate amounts of water
6. Drinking wine beneficial in dementia
7. Drinking milk: Good or bad?
8. Is Drinking Extra Fluids Safe When You’re Sick
9. Could Midlife Alcohol Drinking Lead To Dementia ?
10. Understanding The Link Between Metabolic Syndrome And Drinking Patterns
11. Heavy Drinking Can Increase Stroke Risk
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... ... 27, 2016 , ... More than a third of American adults are considered ... surgery has received increased attention in recent years, as an article published ... weight loss, most people are familiar with the basic requirements of maintaining a healthy ...
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Connor Sports, ... basketball as a partner for the Tamika Catchings Legacy Tour that will ... industry leader in hardwood basketball surfaces in all forms and levels of the game, ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
(Date:5/24/2016)... --   , ... Endpunkte und demonstriert Ebenbürtigkeit bei der Gesamtreinigung des ... guter , Reinigung des ... (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... der MORA-Studie der Phase III für NER1006 (1 ...
(Date:5/24/2016)... Celsion Corporation (NASDAQ: CLSN ... an update on its ongoing OVATION study, a ... the Company,s DNA-based immunotherapy, with the standard of ... advanced ovarian cancer who will undergo neoadjuvant chemotherapy ... IL-12 DNA plasmid vector formulated as a nanoparticle ...
Breaking Medicine Technology: